IP Library › Granted Patent US 11,261,248
Granted Patent B2
US 11,261,248 · App. 16/265,825 · Granted Mar 1, 2022

Restricted immunoglobulin heavy chain mice

Inventors: Lynn Macdonald (Harrison, NY); John McWhirter (Hastings-on-Hudson, NY); Andrew J. Murphy (Croton-on-Hudson, NY)
Assignee: Regeneron Pharmaceuticals, Inc.
C07K16/28A01K67/0278C07K16/00C07K16/461C12N15/8509A01K2217/072A01K2217/15A01K2227/105A01K2267/01C07K2317/10C07K2317/20C07K2317/21C07K2317/24C07K2317/515C07K2317/52C07K2317/56C07K2317/565C07K2317/567C12N2800/204
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,261,248
App. No.
16/265,825
Granted
Mar 1, 2022
Kind
B2
Abstract

Mice having a restricted immunoglobulin heavy chain locus are provided, wherein the locus is characterized by a single polymorphic human V H gene segment, a plurality of human D H gene segments and a plurality of J H gene segments. Methods for making antibody sequences that bind an antigen (e.g., a viral antigen) are provided, comprising immunizing a mouse with an antigen of interest, wherein the mouse comprises a single human V H gene segment, a plurality of human D H gene segments and a plurality of J H gene segments, at the endogenous immunoglobulin heavy chain locus.

Claims (47)

1. A rat or mouse whose germline genome comprises

a restricted endogenous immunoglobulin heavy chain locus characterized by the presence of

(i) only a single human V H gene segment, wherein the single human V H gene segment is a V H 3 segment family member,

(ii) one or more human D H gene segments,

(iii) one or more human J H gene segments, and

(iv) an endogenous immunoglobulin heavy chain constant region nucleic acid sequence comprising an endogenous IgM gene,

wherein the single human V H gene segment, the one or more human D H gene segments, and the one or more human J H gene segments are capable of rearranging to encode a diverse repertoire of human heavy chain variable domains,

wherein each human heavy chain variable domain of the diverse repertoire

(a) comprises framework (FR)1, complementarity determining region (CDR)1, FR2, CDR2, and FR3 sequences that are derived from the single human V H gene segment and CDR3 and FR4 sequences that are distinct,

(b) is operably linked to an endogenous IgM constant region encoded by the endogenous IgM gene, and

(c) is expressed in the context of a cognate light chain, and

wherein the rat or mouse expresses each human heavy chain variable domain of the diverse repertoire in the context of its cognate light chain.

2. The rat or mouse of claim 1 , wherein the restricted endogenous immunoglobulin heavy chain variable region locus comprises a deletion of all or substantially all endogenous V H , D H , and J H gene segments.

3. The rat or mouse of claim 1 , wherein the single human V H 3 segment family member is selected from the group consisting of a V H 3-7 gene segment, a V H 3-9 gene segment, a V H 3-11 gene segment, a V H 3-13 gene segment, a V H 3-15 gene segment, a V H 3-16 gene segment, a V H 3-20 gene segment, a V H 3-21 gene segment, a V H 3-23 gene segment, a V H 3-30 gene segment, a V H 3-30-3 gene segment, a V H 3-30-5 gene segment, a V H 3-33 gene segment, a V H 3-35 gene segment, a V H 3-38 gene segment, a V H 3-43 gene segment, a V H 3-48 gene segment, a V H 3-49 gene segment, a V H 3-53 gene segment, a V H 3-64 gene segment, a V H 3-66 gene segment, a V H 3-72 gene segment, a V H 3-73 gene segment, and a V H 3-74 gene segment.

4. The rat or mouse of claim 1 , further comprising a humanized immunoglobulin light chain locus comprising, in operable linkage: one or more human V L gene segments, one or more human J L gene segments, and an immunoglobulin light chain constant region gene, wherein:

(i) the one or more human V L gene segments are one or more human Vκ gene segments, the one or more human J L gene segments are one or more human Jκ gene segments, and the immunoglobulin light chain constant region gene is an immunoglobulin light chain κ constant region gene or

(ii) the one or more human V L gene segments are one or more human Vλ gene segments, the one or more human J L gene segments are one or more human Jλ, gene segments, and the immunoglobulin light chain constant region gene is an immunoglobulin light chain λ, constant region gene, and

wherein the humanized immunoglobulin light chain locus encodes each cognate light chain for each human heavy chain variable domain of the diverse repertoire, and wherein each cognate light chain comprises a human light chain variable domain.

5. The rat or mouse of claim 4 , wherein the immunoglobulin light chain constant region gene is an endogenous immunoglobulin light chain constant region gene.

6. A mouse whose germline genome comprises

(A) at an endogenous immunoglobulin heavy chain locus, a replacement of all or substantially all

(i) endogenous V H gene segments,

(ii) endogenous D H gene segments, and

(iii) endogenous J H gene segments

with

(i) only a single human V H gene segment, wherein the single human V H gene segment is a V H 3 segment family member,

(ii) one or more human D H gene segments, and

(iii) one or more human J H gene segments,

such that the single human V H gene segment, the one or more human D gene segments, and the one or more human J H gene segments are operably linked to an endogenous IgM constant region gene,

wherein the single human V H , gene segment, the one or more human D H gene segments, and the one or more human J H gene segments are capable of rearranging to encode a diverse repertoire of human heavy chain variable domains,

wherein each human heavy chain variable domain of the diverse repertoire

(a) comprises framework (FR) 1, complementarity determining region (CDR)1, FR2, CDR2, and FR3 sequences that are derived from the single human V H gene segment and CDR3 and FR4 sequences that are distinct,

(b) is operably linked to an endogenous IgM constant region encoded by the endogenous IgM gene, and

(c) is expressed in the context of a cognate light chain, and

(B) at an endogenous immunoglobulin light chain locus, a replacement of all or substantially all

(i) endogenous V L gene segments and

(ii) endogenous J L gene segments

with

(i) a plurality of human V L gene segments and

(ii) a plurality of human J L gene segments

such that the plurality of human V L gene segments and the plurality of human J L gene segments are operably linked to an endogenous immunoglobulin light chain constant region,

wherein

(a) the plurality of human V L gene segments is a plurality of human Vκ gene segments, the plurality of human J L gene segments is a plurality of human Jκ gene segments, and the endogenous immunoglobulin light chain constant region gene is an endogenous immunoglobulin light chain κ constant region gene or

(b) the plurality of human V L gene segments is a plurality of human Vλ, gene segments, the plurality of human J L gene segments is a plurality of human Jλ, gene segments, and the endogenous immunoglobulin light chain constant region gene is an endogenous immunoglobulin light chain λ constant region gene,

wherein the endogenous immunoglobulin light chain locus encodes each cognate light chain for each human heavy chain variable domain of the diverse repertoire, and wherein each cognate light chain comprises a human light chain variable domain, and

wherein mouse expresses each human heavy chain variable domain of the diverse repertoire in the context of its cognate light chain.

7. A cell or tissue derived from the rat or mouse of claim 1 .

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 9, 2019
From: MACDONALD, LYNN; MCWHIRTER, JOHN; GURER, CAGAN; MEAGHER, KAROLINA A.; MURPHY, ANDREW J.
To: REGENERON PHARMACEUTICALS, INC.
Reel/Frame 048827/0498 →
Continuity (5)
Division 13653456 · Oct 17, 2012
Provisional Application 61658459 · Jun 12, 2012
Provisional Application 61597969 · Feb 13, 2012
Provisional Application 61547974 · Oct 17, 2011
Related Publication 20190261612A1 · Aug 29, 2019